BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 37753709)

  • 21. It is time to improve the diagnostic workup of oropharyngeal cancer with circulating tumor HPV DNA: Systematic review and meta-analysis.
    Paolini F; Campo F; Iocca O; Manciocco V; De Virgilio A; De Pascale V; Moretto S; Dalfino G; Vidiri A; Blandino G; Pimpinelli F; Venuti A; Pellini R
    Head Neck; 2023 Nov; 45(11):2945-2954. PubMed ID: 37715656
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Combined P16 and human papillomavirus testing predicts head and neck cancer survival.
    Salazar CR; Anayannis N; Smith RV; Wang Y; Haigentz M; Garg M; Schiff BA; Kawachi N; Elman J; Belbin TJ; Prystowsky MB; Burk RD; Schlecht NF
    Int J Cancer; 2014 Nov; 135(10):2404-12. PubMed ID: 24706381
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Histologic Typing in Oropharyngeal Squamous Cell Carcinoma: A 4-Year Prospective Practice Study With p16 and High-Risk HPV mRNA Testing Correlation.
    Gondim DD; Haynes W; Wang X; Chernock RD; El-Mofty SK; Lewis JS
    Am J Surg Pathol; 2016 Aug; 40(8):1117-24. PubMed ID: 27035614
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Detection of human papillomavirus-16 in fine-needle aspirates to determine tumor origin in patients with metastatic squamous cell carcinoma of the head and neck.
    Begum S; Gillison ML; Nicol TL; Westra WH
    Clin Cancer Res; 2007 Feb; 13(4):1186-91. PubMed ID: 17317828
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Molecular subclassification determined by human papillomavirus and epidermal growth factor receptor status is associated with the prognosis of oropharyngeal squamous cell carcinoma.
    Nakano T; Yamamoto H; Nakashima T; Nishijima T; Satoh M; Hatanaka Y; Shiratsuchi H; Yasumatsu R; Toh S; Komune S; Oda Y
    Hum Pathol; 2016 Apr; 50():51-61. PubMed ID: 26997438
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A comprehensive evaluation of human papillomavirus positive status and p16INK4a overexpression as a prognostic biomarker in head and neck squamous cell carcinoma.
    Deng Z; Hasegawa M; Aoki K; Matayoshi S; Kiyuna A; Yamashita Y; Uehara T; Agena S; Maeda H; Xie M; Suzuki M
    Int J Oncol; 2014 Jul; 45(1):67-76. PubMed ID: 24820457
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The role of human papillomavirus in p16-positive oral cancers.
    Belobrov S; Cornall AM; Young RJ; Koo K; Angel C; Wiesenfeld D; Rischin D; Garland SM; McCullough M
    J Oral Pathol Med; 2018 Jan; 47(1):18-24. PubMed ID: 29024035
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Determination of high-risk HPV status of head and neck squamous cell carcinoma using the Roche cobas HPV test on cytologic specimens and acellular supernatant fluid.
    Wright MF; Weiss VL; Lewis JS; Schmitz JE; Ely KA
    Cancer Cytopathol; 2020 Jul; 128(7):482-490. PubMed ID: 32129949
    [TBL] [Abstract][Full Text] [Related]  

  • 29. HR-HPV E6/E7 mRNA In Situ Hybridization: Validation Against PCR, DNA In Situ Hybridization, and p16 Immunohistochemistry in 102 Samples of Cervical, Vulvar, Anal, and Head and Neck Neoplasia.
    Mills AM; Dirks DC; Poulter MD; Mills SE; Stoler MH
    Am J Surg Pathol; 2017 May; 41(5):607-615. PubMed ID: 28403015
    [TBL] [Abstract][Full Text] [Related]  

  • 30. pRb and CyclinD1 Complement p16 as Immunohistochemical Surrogate Markers of HPV Infection in Head and Neck Cancer.
    Dreyer JH; Hauck F; Barros MHM; Niedobitek G
    Appl Immunohistochem Mol Morphol; 2017; 25(5):366-373. PubMed ID: 26657876
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The utility of p16 immunostaining in fine needle aspiration in p16-positive head and neck squamous cell carcinoma.
    Xu B; Ghossein R; Lane J; Lin O; Katabi N
    Hum Pathol; 2016 Aug; 54():193-200. PubMed ID: 27105759
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Evaluation of high-risk human papillomavirus in sinonasal papillomas and squamous cell carcinomas.
    Kakkar A; Satapathy S; Sikka K; Tanwar P; Deo S; Jain D
    Virchows Arch; 2023 Sep; 483(3):381-392. PubMed ID: 37452847
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Human papillomavirus circulating tumor DNA: a diagnostic tool in squamous cell carcinoma of unknown primary-a pilot study.
    Kais A; Santiago SP; Han PC; Clump DA; Stokes WA; Fancy T; Cui R; Martin E; Turner MT
    Front Oncol; 2024; 14():1376595. PubMed ID: 38628671
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Human papillomavirus DNA and p16 expression in head and neck squamous cell carcinoma in young French patients.
    Molimard C; L'Huillier V; Overs A; Soret C; Algros MP; Mougin C; Guenat D; Mauvais O; Prétet JL
    J Int Med Res; 2021 Jul; 49(7):3000605211022534. PubMed ID: 34232797
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Genetic patterns in head and neck cancers that contain or lack transcriptionally active human papillomavirus.
    Braakhuis BJ; Snijders PJ; Keune WJ; Meijer CJ; Ruijter-Schippers HJ; Leemans CR; Brakenhoff RH
    J Natl Cancer Inst; 2004 Jul; 96(13):998-1006. PubMed ID: 15240783
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Performance of the Roche cobas 4800 high-risk human papillomavirus test in cytologic preparations of squamous cell carcinoma of the head and neck.
    Kerr DA; Pitman MB; Sweeney B; Arpin RN; Wilbur DC; Faquin WC
    Cancer Cytopathol; 2014 Mar; 122(3):167-74. PubMed ID: 24259368
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Detectable Postoperative Circulating Tumor Human Papillomavirus DNA and Association with Recurrence in Patients With HPV-Associated Oropharyngeal Squamous Cell Carcinoma.
    Routman DM; Kumar S; Chera BS; Jethwa KR; Van Abel KM; Frechette K; DeWees T; Golafshar M; Garcia JJ; Price DL; Kasperbauer JL; Patel SH; Neben-Wittich MA; Laack NL; Chintakuntlawar AV; Price KA; Liu MC; Foote RL; Moore EJ; Gupta GP; Ma DJ
    Int J Radiat Oncol Biol Phys; 2022 Jul; 113(3):530-538. PubMed ID: 35157995
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A pilot study to compare the detection of HPV-16 biomarkers in salivary oral rinses with tumour p16(INK4a) expression in head and neck squamous cell carcinoma patients.
    Chai RC; Lim Y; Frazer IH; Wan Y; Perry C; Jones L; Lambie D; Punyadeera C
    BMC Cancer; 2016 Mar; 16():178. PubMed ID: 26940728
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of human papillomavirus infection in oral squamous cell carcinoma: a cohort study of Japanese patients.
    Kouketsu A; Sato I; Abe S; Oikawa M; Shimizu Y; Takahashi T; Kumamoto H
    J Oral Pathol Med; 2016 Sep; 45(8):565-72. PubMed ID: 26711722
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Human papillomavirus E7 serology and association with p16 immunohistochemistry in squamous cell carcinoma of the head and neck.
    Khanal S; Joh J; Kwon AM; Zahin M; Perez CA; Dunlap NE; Silverman CL; Tennant PA; Potts KL; Kloecker GH; Bumpous JM; Ghim SJ; Jenson AB; Redman RA
    Exp Mol Pathol; 2015 Oct; 99(2):335-40. PubMed ID: 26116154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.